Targeted delivery of doxorubicin via estrone-appended liposomes

Shivani Rai, Rishi Paliwal, Bhuvaneshwar Vaidya, Kapil Khatri, Amit Goyal, Prem Gupta, S. P. Vyas

Research output: Contribution to journalArticlepeer-review

43 Scopus citations

Abstract

Estrone-appended liposomal formulation of doxorubicin was designed to enhance the capability of clinically used liposomal doxorubicin formulation with the added advantage of delivery of doxorubicin to its destination site, i.e. cancerous cells over-expressing estrogen receptors (ERs). Estrone was conjugated with distearoyl phosphatidylethanolamine (DSPE) using succinic anhydride as a linker and the conjugate was characterized by IR and mass spectroscopies. Estrone-coupled liposomes were prepared with the composition of egg phosphatidylcholine/cholesterol/distearoyl phosphatidylethanolamine-estrone (PC/CHOL/DSPE-ES) at the molar and drug-lipid ratios of 7:3:0.5 and 0.1:1 (w/w), respectively. The average vesicle sizes of the conventional and estrone-appended liposomes were found to be 193 ± 24 and 207 ± 28 nm, respectively. The fluorescent microscopy studies were performed with estrone-appended liposomes loaded with 6-carboxyfluorescein (6-CF). Results of in vivo biodistribution studies showed that estrone-appended liposomes were effectively taken up by cells expressing ERs. The drug uptake study showed that accumulation of ligand-appended liposomes in the breast and uterus was 13.9 and 12.7 times higher when compared with plain drug, and 11.05 and 10.3 times higher when compared with conventional liposomes, respectively, after 8 h of tail vein intravenous administration. The findings are seminal for selective targeting of antineoplastic agents to the ER, which are frequently over-expressed on carcinoma of breast and uterine origin, and opens the promising possibilities for non-immunogenic, site-specific delivery of bioactive(s) to these sites.
Original languageEnglish (US)
Pages (from-to)455-463
Number of pages9
JournalJournal of Drug Targeting
Volume16
Issue number6
DOIs
StatePublished - Jul 1 2008
Externally publishedYes

Bibliographical note

Generated from Scopus record by KAUST IRTS on 2023-10-12

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'Targeted delivery of doxorubicin via estrone-appended liposomes'. Together they form a unique fingerprint.

Cite this